Rettiganti M - Search Results

1

Antibody-mediated rejection is associated with impaired graft function in pediatric heart transplant recipients.

Knecht KR, Glover A, Dossey AM, Rettiganti M, Gossett J, Frazier EA. Knecht KR, et al. Among authors: rettiganti m. J Heart Lung Transplant. 2015 Aug;34(8):1120-1. doi: 10.1016/j.healun.2015.03.024. Epub 2015 Mar 30. J Heart Lung Transplant. 2015. PMID: 25987310 No abstract available.

2

Insulin pump therapy started at the time of diagnosis: effects on glycemic control and pancreatic β-cell function in type 1 diabetes.

Thrailkill KM, Moreau CS, Swearingen C, Rettiganti M, Edwards K, Morales AE, Kemp SF, Frindik JP, Fowlkes JL. Thrailkill KM, et al. Among authors: rettiganti m. Diabetes Technol Ther. 2011 Oct;13(10):1023-30. doi: 10.1089/dia.2011.0085. Epub 2011 Jun 30. Diabetes Technol Ther. 2011. PMID: 21718094 Clinical Trial.

3

CE: Original Research: Predicting Injurious Falls in the Hospital Setting: Implications for Practice.

Hester AL, Tsai PF, Rettiganti M, Mitchell A. Hester AL, et al. Among authors: rettiganti m. Am J Nurs. 2016 Sep;116(9):24-31. doi: 10.1097/01.NAJ.0000494688.10004.85. Am J Nurs. 2016. PMID: 27513072

4

Prevalence, Patterns, and Predictors: A Statewide Longitudinal Study of Childhood Obesity.

Rouse H, Goudie A, Rettiganti M, Leath K, Riser Q, Thompson J. Rouse H, et al. Among authors: rettiganti m. J Sch Health. 2019 Apr;89(4):237-245. doi: 10.1111/josh.12741. Epub 2019 Feb 11. J Sch Health. 2019. PMID: 30740717

5

A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy.

Knop FK, Urva S, Rettiganti M, Benson CT, Roell WC, Mather KJ, Haupt A, Pratt EJ. Knop FK, et al. Among authors: rettiganti m. Diabetes Obes Metab. 2024 Nov;26(11):5474-5478. doi: 10.1111/dom.15875. Epub 2024 Aug 27. Diabetes Obes Metab. 2024. PMID: 39188238 No abstract available.

6

Effect of Galcanezumab on Total Pain Burden in Patients Who Had Previously Not Benefited from Migraine Preventive Medication (CONQUER Trial): A Post Hoc Analysis.

Ailani J, Andrews JS, Tockhorn-Heidenreich A, Wenzel R, Rettiganti M. Ailani J, et al. Among authors: rettiganti m. Adv Ther. 2022 Oct;39(10):4544-4555. doi: 10.1007/s12325-022-02233-y. Epub 2022 Aug 5. Adv Ther. 2022. PMID: 35930126 Free PMC article. Clinical Trial.

7

Changes in acute headache medication use and health care resource utilization: Results from a randomized, double-blind, placebo-controlled clinical trial evaluating galcanezumab in adults with treatment-resistant migraine (CONQUER).

Ambrosini A, Estemalik E, Pascual J, Rettiganti M, Stroud C, Day K, Ford J. Ambrosini A, et al. Among authors: rettiganti m. J Manag Care Spec Pharm. 2022 Jun;28(6):645-656. doi: 10.18553/jmcp.2022.21375. Epub 2022 Apr 22. J Manag Care Spec Pharm. 2022. PMID: 35451858 Clinical Trial.

8

Does "wearing off" of efficacy occur in galcanezumab-treated patients at the end of the monthly treatment cycle? Post hoc analyses of four phase III randomized trials.

Ailani J, Kuruppu DK, Rettiganti M, Oakes T, Schroeder K, Wietecha L, Port M, Blumenfeld AM. Ailani J, et al. Among authors: rettiganti m. Headache. 2022 Feb;62(2):198-207. doi: 10.1111/head.14257. Epub 2022 Jan 25. Headache. 2022. PMID: 35076090 Free PMC article. Clinical Trial.

9

Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine.

Ament M, Day K, Stauffer VL, Skljarevski V, Rettiganti M, Pearlman E, Aurora SK. Ament M, et al. Among authors: rettiganti m. J Headache Pain. 2021 Aug 26;22(1):100. doi: 10.1186/s10194-021-01307-6. J Headache Pain. 2021. PMID: 34445967 Free PMC article. No abstract available.

10

Impact of Galcanezumab on Total Pain Burden: A Post Hoc Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Episodic Cluster Headache.

Andrews JS, Kudrow D, Rettiganti M, Oakes T, Bardos JN, Wenzel R, Kuruppu DK, Gaul C, Martinez JM. Andrews JS, et al. Among authors: rettiganti m. J Pain Res. 2021 Jul 8;14:2059-2070. doi: 10.2147/JPR.S305066. eCollection 2021. J Pain Res. 2021. PMID: 34267550 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters